Antithrombin inhibition using nanobodies to correct bleeding in hemophilia
Abstract In this issue of EMBO Molecular Medicine, Barbon et al describe a new approach to rebalancing coagulation in patients with hemophilia (PWH) through targeted inhibition of anticoagulant antithrombin (AT) (Barbon et al, 2020). In contrast to previous studies that used RNA interference (RNAi)...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Nature
2020-03-01
|
| coleção: | EMBO Molecular Medicine |
| Acesso em linha: | https://doi.org/10.15252/emmm.202012143 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|